Solid performances during an unprecedented crisis Thierry CHAPUSOT
2020 Annual Results
Jean-Yves SAMSON
Business developments & Outlook Dominique PAUTRAT
Conclusion
Thierry CHAPUSOT
2
2020 ANNUAL RESULTS - Web Conference - 29 March 2021
Qualities revealed by the crisis: agility, responsiveness and the strength of the business model
Financial strength:
A high level for Recurrent Revenue (66%) and the Gross Margin (68%).
Diversity of the portfolio of health-related activities.
An excellent balance sheet structure: €104m in cash at 31/12/2020.
Current bank credit facilities available: €26m.
The Group's ability to manage situations of crisis:
Anticipation and responsiveness in deploying new secure remote access and video- conferencing solutions.
Optimization of Human Resources: taking vacation days and other form of leave available to remain as operational as possible during the reopening face.
Optimization of General Expenses: cancellation of events, postponement of advertising campaigns, reducing activities and travels.
Very strong dedication of all teams throughout the year both remotely and in the field:
Commercial momentum to support the launch of new offerings.
Fulfilment of postponed deliveries.
Annual
Current Operating
Performance
Revenue
Income
Current Operating
€171.75m
€46.65m
margin
(+8.32% vs. 2019)*
(+14.20% vs. 2019)
27.16%
(25.76% in 2019)
Stable sales (+0.49%)
like-for-like
4
2020 ANNUAL RESULTS - Web Conference - 29 March 2021
Pursuing the external growth strategy
Significant strategic acquisitions:
positive contribution of €12.77m to 2020 revenue
Integration and 100% controlling interest acquired in ICT Group.
Creation of MALTA BELGIUM.
Acquisition of a majority stake (56.27%) in PANDALAB.
Acquisition of ASCA INFORMATIQUE.
For information, European developments in October 2019:
Acquisition of a majority stake (80%) in SVEMU in Italy.
Acquisition of a majority stake (60%) in the German distributor I-MEDS.
5
2020 ANNUAL RESULTS - Web Conference - 29 March 2021
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original document
Permalink
Disclaimer
Pharmagest Interactive SA published this content on 29 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 April 2021 15:01:02 UTC.
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows:
- pharmacy software publishing and integration (73%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.;
- publishing of IT solutions for health and medical/social establishments (15.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.);
- development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo).
Net sales are distributed geographically as follows: France (90.9%), Italy (4.9%), Belgium and Luxembourg (2.7%), Ireland and the United Kingdom (0.8%) and Germany (0.7%).